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 OPEN
Signal transducer and activator of transcription-3
licenses Toll-like receptor 4-dependent interleukin
(IL)-6 and IL-8 production via IL-6 receptor-positive
feedback in endometrial cells
JG Cronin1, V Kanamarlapudi1, CA Thornton1 and IM Sheldon1
Interleukin6 (IL-6), actingvia the IL-6 receptor (IL6R) andsignal transducer andactivatorof transcription-3 (STAT3), limits
neutrophil recruitment once bacterial infections are resolved. Bovine endometritis is an exemplar mucosal disease,
characterized by sustained neutrophil infiltration and elevated IL-6 and IL-8, a neutrophil chemoattractant, following
postpartum Gram-negative bacterial infection. The present study examined the impact of the IL6R/STAT3 signaling
pathway on IL-8 production by primary endometrial cells in response to short- or long-term exposure to
lipopolysaccharide (LPS) fromGram-negative bacteria. Tyrosine phosphorylation of STAT3 is required for DNA binding
and expression of specific targets genes. Immunoblotting indicated constitutive tyrosine phosphorylation of STAT3 in
endometrial cells was impeded by acute exposure to LPS. After 24 h exposure to LPS, STAT3 returned to a tyrosine
phosphorylated state, indicating cross-talk between the Toll-like receptor 4 (TLR4) and the IL6R/STAT3 signaling
pathways. Thiswasconfirmedbyshort interferingRNA targeting the IL6R,whichabrogated theaccumulationof IL-6and
IL-8, induced by LPS. Furthermore, there was a differential endometrial cell response, as the accumulation of IL-6 and
IL-8 was dependent on STAT3, suppressor of cytokine signaling 3, and Src kinase signaling in stromal cells, but not
epithelial cells. In conclusion, positive feedback through the IL6R amplifies LPS-induced IL-6 and IL-8 production in the
endometrium. These findings provide a mechanistic insight into how elevated IL-6 concentrations in the postpartum
endometrium during bacterial infection leads to marked and sustained neutrophil infiltration.
INTRODUCTION
The mechanisms of response to pathogens and their pathogen-
associated molecular patterns, such as Escherichia coli and
lipopolysaccharide (LPS), is orchestrated by pattern-recogni-
tion receptors, including the Toll-like receptors (TLRs), and the
subsequent downstream activation of nuclear factor-kB
(NF-kB) and mitogen-activated protein kinase (MAPK)
signaling pathways, resulting in the production of inflamma-
tory cytokines.1,2 The signal transducer and activator of
transcription 3 (STAT3) pathway orchestrates the inflamma-
tory response through cross-talk with pattern-recognition
receptor pathways, such as the TLR family, inducing the
production of proinflammatory signaling cytokines, including
interleukin (IL)-6.3,4 The multifunctional cytokine IL-6 is
produced by many cells, including endometrial cells, in
response to infection and damage, and is critical for the
pattern of leukocyte recruitment and tissue homeostasis.1,2,5–7
During this process, IL-6 signals and activates STAT3 via the
cognate IL-6 receptor (IL6R) complex, which consists of a
heterodimer of IL6Ra and gp130. Upon ligand binding, the
gp130 receptor-associated Janus kinases JAK1, JAK2, and Tyk2
become activated.8 The JAKs in turn phosphorylate tyrosine
motifs within the cytoplasmic region of gp130 resulting in the
association of Src homology domains containing tyrosine
phosphatase-2 and activation of the Ras/Raf/MAPK pathway.
Activation of JAKs also results in the recruitment of signaling
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molecules, including STAT3 and suppressor of cytokine
signaling 3 (SOCS3), an inhibitor of STAT3.9 However, SOCS3
does not directly inhibit STAT3 but acts in a receptor-specific
manner, through interference between gp130 and JAK
activation.10,11 Alternatively, SOCS proteins can be rapidly
induced by pathogen-associated molecular patterns, act as
regulators of LPS-induced activation in macrophages, and
interact with NF-kB and TLR pathway components, including
the adaptor Mal.12–15 Furthermore, SOCS proteins activate
MAPK pathways, particularly extracellular signal-regulated
kinases (ERK1/2), which is required for endometrial decidua-
lization in mice and humans, and for conception in cows.16–18
During acute inflammation, the chemokine IL-8 initially
recruits neutrophils, which are later replaced by a more
sustained population of mononuclear cells. IL-6 and its soluble
receptor are important for this transition of leukocyte
recruitment, but in some diseases the transition fails, demon-
strated by persistent neutrophil infiltration.5,6 An exemplar
mucosal disease, where persistent neutrophil recruitment is a
key feature, is postpartum endometritis in Bos taurus. Uterine
disease of dairy cows is of major economic importance, costing
the European Union dairy industry h1.4 billion per year.
Approximately 90% of dairy cattle acquire bacterial contam-
ination of the uterine lumen after parturition, leading to
chronic inflammation and endometritis in 40% of cases.
Endometritis is refractory to current treatments and leads to
significant morbidity, mortality, and infertility.19 Persistent
inflammation, even following bacterial clearance, is a major
feature of the disease and is associated with marked and
sustained neutrophil infiltration, elevated IL-6, and IL-8, and
pus accumulating in the uterine lumen.19 However, the
mechanism that drives these events is unclear. We hypothe-
sized that there is cross-talk between TLR signaling and STAT3
pathways in bovine endometrial cells, sustaining the produc-
tion of IL-6 and IL-8 via IL6R signaling.
RESULTS
Acute LPS or IL-6 exposure reduced STAT3a
phosphorylation in stromal cells
To investigate cross-talk between the TLR4 pathway and the
STAT3 pathway in endometrium, primary epithelial and
stromal cells were isolated and exposed to LPS for short
periods of time: from 15 to 120min. Isolated endometrial cell
populations contained less than 0.8%CD45-positive cells.2 Two
STAT3 isoforms originate from alternate splicing, STAT3a
(92 kDa) and STAT3b (84 kDa). The STAT3b isoformhas been
described as a dominant negative regulator of STAT3a and has
a critical role in the control of systemic inflammation.20
Exposure of epithelial cells to LPS did not alter the abundance of
STAT3a or STAT3b (Figure 1a). In stromal cells, STAT3awas
more evident than the negative regulator STAT3b isoform, and
abundance of STAT3a was consistent throughout LPS exposure
(Figure 1b). The activation of STAT3a requires tyrosine phos-
phorylation (Y705) for dimerization,21 cytoplasmic or nuclear
tyrosine phosphorylated STAT3a activation was not affected by
acute exposure to LPS in epithelial cells (Figure 1a). However,
stromal cells exposed to LPS showed rapid loss of cytoplasmic
tyrosine phosphorylated STAT3a and nuclear STAT3a within
15min and reduced tyrosine phosphorylated STAT3a was
evident for up to 120min after LPS exposure (Figure 1b).
The IL6R is important for the coordinated transition of
leukocyte recruitment during inflammation.6 To investigate
whether endometrial cells, can respond to IL-6, through a
cognate receptor, epithelial or stromal cells were exposed to
recombinant IL-6 from 15 to 120min. Tyrosine phosphoryla-
tion of STAT3a was unaffected in the cytoplasmic fraction of
LPS-exposed epithelial cells, but decreased nuclear tyrosine
phosphorylated STAT3a was evident (Figure 1c). Whereas
IL-6-exposed stromal cells showed a loss of cytoplasmic and
nuclear tyrosine phosphorylated STAT3a within 15min and
showed reduced tyrosine phosphorylated STAT3a for up to
120min (Figure 1d). Together, these data provide evidence for
a functional IL6R on endometrial cells, and cross-talk between
the TLR4 signaling pathway and the STAT3 signaling pathways
in stromal cells but not epithelial cells.
IL6R, STAT3, andSOCS3 are essential for LPS-induced IL-6
production in stromal cells but only IL6R is required in
epithelial cells
As endometrial stromal cells responded to exogenous IL-6,
evident by rapid reduction in tyrosine phosphorylated STAT3a
(Figure 1d), we hypothesized that the IL-6 produced from LPS
exposed endometrial cells1,2 may signal via the IL6R in a
positive feedback system. To explore this, major components of
the IL6R signaling pathway were targeted with short interfering
RNA (siRNA). Knockdown of IL6R, STAT3, or SOCS3 did not
affect the cell viability of epithelial or stromal cells (Figure 2a
and b). During 24 h LPS exposure, knockdown of IL6R reduced
IL-6 and IL-8 accumulation in epithelial and stromal cell
supernatants (Figure 2c–f). This indicates that positive
feedback through the IL6R complex is required for
sustained IL-6 and IL-8 production during TLR4 signaling
in endometrial cells. Depletion of STAT3 or SOCS3 had no
effect on IL-6 production in epithelial cells (Figure 2c), but
stromal cells required STAT3 and SOCS3 for IL-6 production
(Figure 2d). Furthermore, depletion of STAT3 or SOCS3 had
no effect on IL6R gene expression in epithelial cells (Figure 2g),
but in stromal cells knockdown of STAT3 resulted in increased
expression of IL6R (Figure 2h). This indicates that STAT3 has a
role in limiting IL6R signaling in stroma, potentially through
suppression of IL6R gene expression.
IL6R and STAT3 are essential for SOCS3mRNA expression
The SOCS family of proteins have a role in modulating TLR
signaling and cytokine responses, and SOCS3 expression was
necessary for the pro-inflammatory effects of IL-6 in mouse
macrophages.15 To explore why SOCS3 is important for
LPS-induced IL-6 production in endometrial stromal cells but
not epithelial cells, we next investigated SOCS3 status during
TLR4 activation. Analysis of whole-cell protein by immuno-
blotting indicated low basal SOCS3 protein levels in untreated
and LPS-exposed epithelial cells (Figure 3a). In contrast,
SOCS3 protein was evident in untreated and LPS-exposed
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stromal cells (Figure 3a). Furthermore, SOCS3 protein was
dependent on STAT3 activation shown by the reduction of
SOCS3 protein in the presence of Stattic (2 mM Figure 3a), a
small molecule that inhibits STAT3 activation and
dimerization by binding to an SH2 domain.22 The transcript
stability of SOCS3 is dependent on ERK1/2 in murine
fibroblasts and hepatocytes.23 However, an ERK1/2 activation
inhibitor (10 mM), a cell-permeable peptide corresponding to
the N-terminus of MEK1, had no effect on SOCS3 protein in
endometrial stromal cells (Figure 3a).
We next monitored the expression of SOCS3 mRNA
after siRNA-targeted knockdown of IL6R, STAT3, or SOCS3.
In support of the protein data, depletion of STAT3 reduced
SOCS3 gene expression in stromal cells, but had no effect in
epithelial cells (Figure 3b and c). However, despite the low
abundance of SOCS3 protein in epithelial cells (Figure 3a),
epithelial and stromal cells had similar levels of SOCS3 gene
expression. This low abundance of protein may be due to the
stability of SOCS3 mRNA and the short half-life of SOCS3
protein in epithelial cells.23 Furthermore, siRNA targeting
IL6R reduced SOCS3 expression in stromal cells (Figure 3c).
These data indicate that SOCS3 expression is dependent on IL6R
complex signaling and STAT3 in stromal cells, providing further
evidence for a positive feedback loop via the IL6R complex.
Usually, SOCS3 perturbs STAT3 dimerization and
phosphorylation by blocking SH2 docking of JAK proteins.10,11
Thus, we assessed whether SOCS3 had a role in blocking the
tyrosine phosphorylation of STAT3a in endometrial cells.
Depletion of SOCS3 increased the tyrosine phosphorylation of
STAT3a in epithelial cells but not stromal cells (Figure 3d),
indicating differential roles of SOCS3 in each cell type.
Interestingly, depletion of IL6R did not affect tyrosine
phosphorylation of STAT3 (Figure 3d).
As the depletion of SOCS3 results in reduced IL-6 production
in stromal cells (Figure 2d), we investigated whether exposure
to LPS or IL-6 would directly affect SOCS3 protein
abundance. To this end, stromal cells were exposed to LPS
or IL-6 from 15 to 120min, and cytoplasmic and
nuclear protein fractions were isolated and analyzed by
immunoblotting. Here, SOCS3 was shown to reside in the
cytoplasm and nuclear compartments in untreated stromal
cells. However, exposure to LPS resulted in rapid loss of SOCS3
protein from the cytoplasm within 30min, whereas nuclear
SOCS3 was unaffected (Figure 3e). Exposure of stromal cells to
IL-6 resulted in the loss of SOCS3 protein from both the
cytoplasmic and nuclear compartment (Figure 3e). This is
further evidence that SOCS3 may modulate TLR4 signaling in
stromal cells.
Figure 1 Treatment of stromal cells with lipopolysaccharide (LPS) or interleukin 6 (IL-6) rapidly reduces tyrosine phosphorylated signal transducer and
activator of transcription-3 (STAT3). Epithelial (a, c) and stromal (b, d) cells were treated with LPS (a, b; 1mgml 1) or IL-6 (c, d; 10 ngml1) for 0–
120min. Cytoplasmic and nuclear cell fraction proteinswere extracted, and analyzed by immunoblotting for tyrosine phosphorylatedSTAT3a (Y705) and
total STAT3, with a-tubulin cytoplasmic or H3 nuclear controls. Average peak densities of phosphorylated STAT3 (Y705) normalized to total STAT3 are
presented as meanþ s.e.m. Immunoblots are representative of two experiments and analyzed by analysis of variance, using the Dunnett’s multiple
comparison test to compare with time 0, **Po0.01, *Po0.05.
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SOCS3 is tyrosine phosphorylated in response to many
growth factors anduponphosphorylation interactswith theRas
inhibitor p120 (RasGAP), resulting in sustained Ras-dependent
activation of ERK1/2.16 Considering ERK1/2may be important
for SOCS3 stability, we next explored whether SOCS3
interacted with RasGAP using co-immunoprecipitation and
immunoblot analysis. Here, endometrial stromal cells showed
reduced RasGAP protein after LPS exposure, as evidenced by
reduced immunoprecipitation of RasGAP protein (Figure 3f).
However, no evidence of SOCS3 protein was observed in the
coimmunoprecipitate (data not shown).
InhibitionofSrckinases reduced IL-6and IL-8production in
LPS-exposed stromal cells
The observed reduction in RasGAP protein (Figure 3f) did not
appear to be associated with SOCS3 protein interaction, as
demonstrated by coimmunoprecipitation, at the time points
analyzed (30 and 60min). Furthermore, farnesyl thiosalicylic
acid, a synthetic farnesyl cysteine mimic that blocks anchorage
of Ras oncoproteins to the cell membrane and to Ras-escort
chaperones, had no effect on LPS-induced IL-6 or IL-8
production, or cell viability in stromal cells (Figure 4a–c).
So, to explore other potential routes of cross-talk between
SOCS3 and TLR4, we next investigated the role of JAK kinases.
SOCS3 regulates IL6R signaling by binding to JAK kinases and
gp130, interfering with STAT3 activation in response to
IL-6.10,11 To investigate whether cross-talk between SOCS3
activation and the TLR4 signaling pathway required JAK
kinases, we used Ruxolitinib, a small-molecule ATP mimetic,
which is an inhibitor of both JAK1 and JAK2. However,
Ruxolitinib had no effect on LPS-induced IL-6 or IL-8
production, or on the viability of stromal cells (Figure 4d–f).
Constitutively active Src kinases, in mouse embryonic
fibroblasts, are involved in the phosphorylation of IL-6-
induced SOCS3, and this activation is independent of JAK
kinases.24 So, to investigate whether Src kinases contributed to
SOCS3 cross-talk with the TLR4 pathway, 1-(1,1-dimethylethyl)-
3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
(PP1), a potent, reversible, ATP-competitive, and selective
inhibitor of the Src family of protein tyrosine kinases, without
significantly affecting JAK2, was used during LPS exposure of
stromal cells. Inhibition of Src kinases in LPS-exposed stromal
cells reduced IL-6 and IL-8 production without significantly
affecting cell viability (Figure 4g–i). Taken together, these data
provide evidence that sustained IL-6 and IL-8 production in
LPS-exposed stromal cells depends on positive feedback via the
IL6R and activation of Src kinases.
Figure 2 Inflammatory mediator secretion is dependent on the
interleukin-6 receptor (IL6R) signaling pathway in endometrial cells.
Epithelial (a, c, e, g) and stromal (b, d, f, h) cells were cultured for 24 h in
medium plus vehicle (V) or media containing LPS (1 mgml1). In each
independent set of experiments, cells received vehicle alone, vehicle plus
short interfering RNA (siRNA) targeting IL6R (siIL6R), STAT3 (siSTAT3),
SOCS3 (siSOCS3), or vehicle plus scrambled siRNA control (Scrambled)
18 h before lipopolysaccharide (LPS) treatment. Cell viability was
assessed byMTT assay (a, b). Concentrations of IL-6 (c, d) and IL-8 (e, f)
in cell supernatants were measured by ELISA. Data are presented as
meanþ s.e.m., and analyzed by analysis of variance (ANOVA), using the
Bonferroni post hoc multiple comparison test to compare scrambled
siRNA plus LPS to targeted siRNA plus LPS, ***Po0.001, **Po0.01,
*Po0.05. Total RNA was extracted and the mRNA levels of IL6R (g,h) in
cells was assessed by quantitative PCR (normalized to ACTB and
RPL19). Data are presented as meanþ s.e.m., and analyzed by ANOVA,
using the Bonferroni post hoc multiple comparison test to compare
scrambled siRNA plus LPS to targeted siRNA plus LPS, **Po0.01,
*Po0.05. Data represent at least three independent experiments.
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Polarized epithelial cells modulate STAT3 regulation of
stromal cell IL-8 production
Epithelial cellsmay impact stromal cell function inmucosa, and
human endometrial epithelial cell secretions modulate the
response to TLR ligands in dendritic cells.25 To begin to explore
whether epithelial cells might modulate stromal cell responses
to LPS during STAT3 inhibition, we exploited a co-culture
model using polarized epithelial cells in a Transwell insert that
can be placed above stromal cells cultured in a 24-well plate.7
We used Stattic (2 mM) as a strategy to be able to inhibit STAT3
Figure 3 Treatment of stromal cells with lipopolysaccharide (LPS) or interleukin 6 (IL-6) reduces suppressor of cytokine signaling 3 (SOCS3) protein.
Epithelial or stromal cells (a) were treated with vehicle, ERK inhibitor (10 mM; ERKi) or Stattic (2 mM; Statt) for 30min before and during treatment with LPS
(1mgml 1) for 24 h.Whole-cell protein was extracted and analyzed by immunoblotting for SOCS3, and a-tubulin as control. Epithelial (b) and stromal (c)
cellswere cultured for 24 h inmediumplus vehicle (V) ormedia containing LPS (1 mgml1). In each independent set of experiments, cells received vehicle
alone (V), vehicle plus short interfering RNA (siRNA) targeting IL6R (siIL6R), STAT3 (siSTAT3), SOCS3 (siSOCS3), or vehicle plus scrambled siRNA
control (Scrambled) 18 h before LPS exposure. Total RNA was extracted and the mRNA levels of SOCS3 were assessed by quantitative PCR
(normalized to ACTB andRPL19). Data are presented as meanþ s.e.m., and analyzed by analysis of variance (ANOVA), using the Bonferroni post hoc
multiple comparison test to compare scrambled siRNA plus LPS with targeted siRNA plus LPS, **Po0.01, *Po0.05. Data represent at least three
independent experiments. Endometrial cells (d) were cultured for 24 h in medium plus vehicle (V) or media containing LPS (1 mgml1). In each
independent set of experiments, cells received vehicle alone (V), vehicle plus siRNA targeting IL6R (siIL6R), STAT3 (siSTAT3), SOCS3 (siSOCS3), or
vehicle plus scrambled siRNA control (Scrambled) 18 h before LPS exposure. Whole-cell protein was extracted and analyzed by immunoblotting for
STAT3 (Y705), STAT3, and a-tubulin as control. Average peak densities of STAT3 (Y705) normalized to a-tubulin are presented as mean + s.e.m. and
analyzed by ANOVA, using Dunnett’s multiple comparison test to compare with scrambled, ***Po0.001. Stromal cells (e) were treated with LPS
(1mgml 1) or IL-6 (10 ngml1) for 0–120min.Cytoplasmic andnuclear cell fraction proteinswereextracted, andanalyzedby immunoblotting forSOCS3
and a-tubulin cytoplasmic or H3 nuclear controls. Average peak densities of SOCS3 normalized to a-tubulin or H3 are presented as meanþ s.e.m. and
analyzed by ANOVA, using Dunnett’s multiple comparison test to compare with time 0, **Po0.01, *Po0.05. Stromal cells (f) were treated with LPS
(1mgml 1) for 0, 30, or 60min. Immunoprecipitated (IP) protein was analyzed by immunoblotting using RasGAP antibody. The Immunoblot is
representative of two experiments.
ARTICLES
MucosalImmunology | VOLUME 9 NUMBER 5 | SEPTEMBER 2016 1129
in epithelial and stromal cells in co-culture, as contempora-
neous siRNAof epithelial and stromal cells was impractical.We
first confirmed Stattic inhibited STAT3a tyrosine phosphor-
ylation in the presence of LPS inmonocultures of epithelial and
stromal cells (Figure 5a), whereas LPS alone or an ERK
inhibitor in the presence of LPS had no substantive effect on
STAT3a abundance. Stattic also reduced the accumulation of
IL-6 and IL-8 in monocultures of epithelial cells and stromal
cells that were treated with LPS (Figure 5b–e), although Stattic
also reduced cell viability to a similar level in epithelial and
stromal cells (Figure 5f, g). As IL-6 drives IL-8 production, we
then examined how stromal cell IL-8 production in response to
LPS is modulated by the presence of epithelial cells during
STAT3 inhibition. We compared IL-8 accumulation in the
basolateral compartment amongst polarized epithelial cell
monocultures, epithelial-stromal co-cultures, and stromal cell
monocultures, which were exposed to LPS and/or Stattic. The
accumulation of IL-8 in response to LPS in the stromal
compartment of the culture system did not differ significantly
between stromal cells in monoculture and stromal cells
Figure 4 Src kinase inhibition attenuated lipopolysaccharide (LPS)-induced secretion of inflammatory mediators in stromal cell supernatants. Stromal
cells (a–i) were cultured for 30min in medium containing vehicle (V) or medium containing inhibitors (farnesyl thiosalicylic acid (FST), 100 nM, 1 mM or
10mM; ruxolitinib (RUX), 40 nM, 400 nM or 4 mM; 1-(1,1-dimethylethyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP1), 54 nM, 540 nM or
5.4 mM) before and during treatment with control medium or LPS (1 mgml1) for 24 h. Concentrations of accumulated IL-6 (a, d, g) and IL-8 (b, e, h) in cell
supernatants were measured by ELISA. Data are presented as meanþ s.e.m., and analyzed by one-way analysis of variance (ANOVA), using the
Bonferroni post hocmultiple comparison test to compare vehicle plus LPS to vehicle or vehicle plus LPS and inhibitor, ***Po0.001, **Po0.01. Stromal
cell viability was assessed by MTT assay (c, f, i), expressed as viability compared with medium plus LPS. Data are presented as meanþ s.e.m., and
analyzed by ANOVA, using the Bonferroni post hoc multiple comparison test to compare with LPS alone.
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co-cultured with epithelial cells, but the expected reduction in
IL-8 accumulation in cells treated with Stattic was only evident
for stromal cell monocultures, and not for stromal cells co-
cultured with epithelial cells (Figure 5h). These data provide
evidence that the regulation of the innate immune response by
STAT3 signaling in the stroma may be modulated by epithelial
cells in the endometrium.
DISCUSSION
During inflammation, IL6R signaling increases IL-8
production, resulting in increased neutrophil chemotaxis.6
Bovine endometritis is an exemplar mucosal disease,
characterized by sustained neutrophil infiltration and elevated
IL-6 and IL-8 during Gram-negative bacterial infection. Here,
we provide evidence that STAT3 licenses TLR4-dependent IL-6
and IL-8 production via IL6R-positive feedback in endometrial
cells.
To demonstrate a direct interaction between the TLR4 and
STAT3 pathways, we exposed endometrial cells to LPS for
short periods of time. This acute TLR4 signaling reduced
tyrosine-phosphorylated STAT3 in stromal cells but did not
affect STAT3 in epithelial cells. Furthermore, chronic exposure
to LPS returned STAT3 to its previous tyrosine-phosphorylated
state, suggesting a positive feedback system, putatively through
the IL6R. Using targeted siRNA, IL6R proved to be critical in
maintaining IL-6 and IL-8 production in epithelial and stromal
cells. However, epithelial and stromal cells showed a differential
signaling response in the presence of LPS when STAT3 or
SOCS3 were targeted with siRNA. Reducing STAT3 or SOCS3
in epithelial cells, did not affect IL-6 or IL-8 production,
whereas STAT3 and SOCS3 were essential for IL-6 production
in stromal cells. This is in contrast to macrophages where
SOCS3 is a negative regulator of IL-6 signaling.26 Interestingly,
SOCS3 protein could not be detected in epithelial cells, but the
expression levels of SOCS3 were similar to stroma. The
underlying explanation is not known, but SOCS3 protein
has a short half-life and theMEK-ERK1/2 cascade is important
in the regulation of SOCS3 mRNA stability;23 and we have
previously shown that MEK-ERK1/2 inhibition is effective at
reducing IL-6 and IL-8 production in stromal cells, but not
epithelial cells.1,2 This suggests that ERK1/2 is important for
IL-6 and IL-8 production in stromal cells through stabilization
of SOCS3 mRNA. We also considered that although the usual
Figure 5 Stattic reduces inflammatory mediator secretion from
endometrial cells. Epithelial or stromal cells (a) were treated with vehicle,
ERK inhibitor (10 mM), or Stattic (2 mM) for 30min before and during
treatment with lipopolysaccharide (LPS) for 24 h. Whole-cell protein was
extracted and analyzed by immunoblotting for tyrosine phosphorylated
STAT3a (Y705), total STAT3, and a-tubulin as control. Epithelial (b, d, f)
and stromal (c, e, g) cells were cultured for 30min in medium containing
vehicle orStattic (2mM) before and during treatmentwith controlmediumor
LPS (1 mgml1) for 24 h. Concentrations of interleukin 6 (IL-6;b, c) and IL-
8 (d, e) were measured in supernatants by ELISA. Data are presented as
meanþ s.e.m., and analyzed by analysis of variance (ANOVA), using the
Bonferroni post hoc multiple comparison test to compare LPS alone with
vehicle or LPSplusStattic, ***Po0.001, **Po0.01, *Po0.05.Cell viability
was assessed by MTT assay and expressed as percentage of vehicle
control (f, g). Endometrial cells (h) were cultured as polarized epithelial
monocultures in Transwell inserts, co-cultures of polarized epithelia above
stromal cells, or stromal cell monocultures. The stromal compartment was
treated with vehicle or Stattic (2 mM) for 30min before and during exposure
to LPS for 24 h. Concentrations of accumulated IL-8 in the stromal
compartment were measured by ELISA. Data are presented as
meanþ s.e.m., and analyzed by ANOVA, using the Bonferroni post hoc
multiple comparison test to compare LPS alone with vehicle or LPS plus
Stattic in each treatment group, ***Po0.001.
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role of SOCS3 is to inhibit STAT3 activation, SOCS3 also
binds to RasGAP, activating Ras and maintaining ERK
activation (Figure 6).16 Here, RasGAP protein was reduced
after 30min exposure to LPS, but an association between
SOCS3 and RasGAP could not be shown, and farnesyl
thiosalicylic acid, an inhibitor of Ras, had no effect on IL-6
or IL-8 production.
Another potential route of cross-talk between the IL6R and
TLR4 pathway is the JAK kinases. Upon ligand binding, IL6R
heterodimerizes with gp130 receptor, activating JAK1, JAK2,
and Tyk2 and in turn STAT3.8,9 However, using the JAK 1/2
inhibitor Ruxolitinib had no effect on IL-6 or IL-8 production
in endometrial stromal cells. A further consideration was that
constitutively active Src kinases can interact with components
of the IL6R/STAT3 pathway independently of JAK kinases.24
Therefore, we used an inhibitor of Src kinases, PP1, which
reduced IL-6 and IL-8 production in stromal cells exposed to
LPS. The differential cytokine and chemokine responses
between epithelial and stromal cells were dependent on
cross-talk between the IL6R and TLR signaling pathways,
and involved the Src kinases, SOCS3, and STAT3 in stromal
cells. Differential regulation of TLR signaling pathways via
STAT3, SOCS3, and Src kinases may reflect evolutionary
divergence between epidermis and mesenchyme. During
parturition, the endometrium experiences extensive tissue
damage, resulting in loss of epithelium, and ubiquitous
contamination with bacteria. The epithelium is the first line
of defense against bacteria and under normal function forms an
impervious barrier; however, direct exposure of the underlying
stroma to bacteria and their ligands may initiate a chain
of events in stroma resulting in sustained IL-8 production
and neutrophil infiltration. Excessive neutrophil infiltrate
would be detrimental to the resolution of inflammation, as
IL6R is shed from apoptotic neutrophils, promoting IL6R
signaling. This is evidenced by neutrophil depletion resulting
in reduced local soluble IL6R levels and the resolution of
inflammation.27
The activation of IL6R leads to changes in target gene
expression via the transcription factor STAT3.4 Signaling via
IL6R and STAT3 activate factors associated with IL-8
production, including NF-kB, a transcription factor essential
for IL8 gene transcription.28,29 Furthermore, in some
instances, the activation of NF-kB is inhibitory to IL-6
signaling, and some genes have overlapping competitive
binding sites for STAT3 and NF-kB.30 Temporal binding of
transcription factors to gene promoters may explain why acute
TLR signaling initially suppresses tyrosine phosphorylation of
STAT3 in stromal cells to prevent competitive binding of
STAT3 and NF-kB on the IL6 promoter. However, chronic
TLR4 signaling requires STAT3 tyrosine activation to induce
cooperation between STAT3 andNF-kBon the IL8promoter.29
Indeed, in response to IL-1 receptor activation, a similar
pathway to TLR4 signaling, STAT3 forms a complex with the
p65 subunit of NF-kB, binding to the human IL8 promoter,
inducing gene expression.28,29 This IL-1 receptor activation is
in contrast to IL-6 signaling in which phosphorylated STAT3 is
recruited and p65 is not.29 Other forms of cross-talk between
the TLR and IL6R signaling pathways include the NF-kB-
dependent gene expression of inhibitors of STAT3 activation,
such as SOCS3 and factors that are involved in TLR signaling,
including LPS-binding protein.31
The transition from neutrophil to mononuclear
cell infiltration is an important process during resolution
of mucosal inflammation.5,6 However, during bovine
endometritis this transition is dysregulated with sustained
influx of neutrophils.19 Here, we show that cross-talk between
TLR signaling and STAT3 pathways, in bovine endometrial
cells, sustains production of IL-6 and IL-8 via IL6R
signaling (Figure 6). IL-6 has been shown to amplify TLR-
mediated cytokine and chemokine production in other
diseases, including rheumatic inflammatory diseases.4,32
Furthermore, activation of the IL6R signaling pathway in
the endometrium during infection may also have con-
sequences for fertility. For example, STAT3 and SOCS3 have
critical roles in implantation and decidualization.33–37 Con-
versely, sustained STAT signaling results in failure of
uterine implantation in mice.38 In humans, cAMP stimulated
Figure 6 Cross-talk between interleukin 6 receptor (IL6R) and Toll-like
receptor 4 (TLR4) signaling pathways in endometrial stromal cells during
acute and chronic exposure to lipopolysaccharide (LPS). Acute exposure
to LPS (1) activates nuclear factor-kB (NF-kB) and mitogen-activated
protein kinase (MAPK) signaling pathways (2) and blocks STAT3a
tyrosine phosphorylation (3) leading to the enhanced production of
interkleukin (IL)-6 and IL-8 (4). IL-6 (5), throughapositive feedforward loop
via IL6R (6), results in tyrosine phosphorylation of STAT3a and sustained
production of IL-6 and IL-8, putatively through activated Src kinase and
ERK1/2 MAPK signaling pathways (7). The production of IL-6 and IL-8 is
abrogated by inhibition of STAT3 or Src kinases, or by depletion of IL6R,
STAT3, or SOCS3 with short interfering RNA (siRNA; red arrows indicate
putative routes of cross-talk).
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SOCS3 expression during decidualization of endometrial
stromal cells, but overexpression of SOCS3 retarded decid-
ualization.35 In cattle, SOCS3 expression increases during
implantation, around day 20 of pregnancy, and is induced
by interferon-t, an important signaling cytokine during
embryo recognition.39,40 Therefore, balanced activation of
the STAT/SOCS signaling pathway is essential for fertility.
However, during uterine infection, TLR4 cross-talk with the
IL6R pathway may perturb this balance and these concepts
need to be explored further.
The bovine endometrium readily yields purified populations
of stromal and epithelial cells that are almost devoid of immune
cells, which generates a tractable model for in vitro analysis of
mucosal cells.2,41 These stromal cell and epithelial cells are
clearly distinct populations, as evidenced by morphology,
fluorescence-activated cell sorting (FACS) analysis, and
differential secretion of prostaglandins.2,42 The role of STAT3
signaling in stromal but not epithelial cell innate immunity, in
the present study, is further evidence that the epithelial and
stromal populations are distinct. This dependence on STAT3 in
stromal cells may reflect the cellular lineage, with STAT3
often considered a mesenchymal cell marker.43 However, there
is likely heterogeneitywithin both the stromal and epithelial cell
populations as both populations contain stem cells that can
differentiate into varied tissue cells.43 Future work might
explore if the roles of IL6R, STAT3, and SOCS3 are a
consistent feature among all stromal cells, or associated with
specific subpopulations of stromal cells. Although the in vitro
cell preparations used in the present study contain very few
immune cells, in vivo immune cells in the endometrium
likely contribute to regulating the mucosal inflammatory
response.25 A further consideration of intercellular commu-
nication is the cross-talk between stromal and epithelial cells
in vivo and one of the features of the regulation of IL6R
signaling that warrants further investigation is the relationship
between epithelial and stromal cells. In the present study, there
was evidence that the STAT3 regulated inflammatory response
by stromal cells was modulated by the presence of epithelial
cells when in co-culture. However, recent evidence shows
that the inhibition of STAT3 with Stattic is less specific than
first thought and has a similar binding affinity for STATs
other than STAT3.22,44 Future work will be challenging in the
primary cells used in the present study, but insights could be
obtained using conditional knock-outs in mice. The role
of IL6R and STAT3 in driving inflammation may provide an
opportunity for therapeutics to restrain the persistent
neutrophil influx in the mucosa, even after bacteria are
eliminated.
In summary, we show that STAT3 licenses TLR4-dependent
IL-6 and IL-8 production in endometrial cells via the IL6R
during the innate immune response. Surprisingly, there was a
differential endometrial cell response, as the accumulation of
IL-6 and IL-8 was dependent on SOCS3 and Src kinase
signaling in stromal cells, but not epithelial cells. These
findings are important because they uncover a role for the
IL6R and STAT3 pathway in mucosal innate immunity, which
contrast with those reported in hematopoietic cells. Further-
more, these findings could be translated to use of inhibitors of
STAT3/IL6R signaling in the uterus to limit the severity of
endometritis.
METHODS
Endometrial cell culture. Healthy uteri were collected from cattle
processed as part of the normal work of an abattoir, as described
previously.1,2 Briefly, the endometrium was dissected from the uterus
and enzymatically digested, and the endometrial epithelial and stromal
cell populations were isolated by their differential adhesion to cell
culture flasks. The absence of immune cell contamination was
confirmed by FACS analysis, as described previously.2 Briefly, 1 107
cells per ml endometrial epithelial cells, stromal cells, and whole blood
were suspended in bovine serum albumin stain buffer (BDBiosciences,
East Rutherford, NJ) for FACS analysis. Cells were stained with
R-Phycoerythrin-conjugated mouse anti-CD45 hematopoietic cell
marker (MA1–81458; Thermo Fisher Scientific, Waltham, MA);
allophycocyanin-conjugated mouse anti-pan-cytokeratin (ab106166;
Abcam, Cambridge, UK) as a marker of epithelia, fluorescein
isothiocyanate-conjugated mouse anti-vimentin (BM5501F; Acris
Antibodies, Herford, Germany) as a mesenchymal cell marker, or
isotype controls, R-Phycoerythrin-conjugated anti-mouse IgG1
(PA5–33180; Thermo Fisher Scientific); allophycocyanin-conjugated
anti-mouse IgG1 (406609; BioLegend Inc., San Diego, CA); or
fluorescein isothiocyanate-conjugated anti-mouse IgG2a (407105;
BioLegend Inc.), respectively. Analysis was performed on a BD
FACSAria III cell sorter instrument using BD FACSDiva v6.1 software
(BD Biosciences), using at least 1 104 live cells.
Endometrial cells were maintained in RPMI 1640 medium,
supplemented with 10% fetal bovine serum, 50 IUml 1 penicillin,
50 mgml 1 streptomycin, and 2.5 mgml 1 amphotericin B (Sigma,
St Louis, MO). However, treatments were carried out in serum-free
OPTI-MEM (Invitrogen, Thermo Fisher Scientific, Waltham, MA) to
exclude the possibility of soluble IL6R signaling. Cells were plated at a
density of 1 105 cells per ml in 6-, 12-, 24-well plates (Helena
Bioscience, Gateshead, UK) or in 25, 75, or 150 cm2 flasks (Nunc,
Rochester, NY).
Endometrial cell culture treatments. Ninety per cent confluent
endometrial stromal and epithelial cells were exposed to 1 mgml 1
ultrapure LPS from E. coli 0111:B4 (InvivoGen, Toulouse, France) or
10 ngml 1 recombinant bovine IL-6 (Kingfisher Biotech, St Paul,
MN). This IL-6 concentration activates STAT3 in human dendritic
cells.45 Furthermore, IL-6 concentrations average 20 ng g 1 of vaginal
mucus in the first week postpartum, and supernatants from endo-
metrial explants exposed to LPS accumulate 6 ngml 1 IL-6 after
24 h.7,46 Each experiment used at least three animals, and treatments
were replicated at least twice. Cells were collected in PhosphoSafe
Extraction Reagent (EMD Millipore, Watford, UK) and stored
at 201C for immunoblotting.
Enzyme linked immunosorbent assay. Concentrations of bovine
IL-6 were measured in supernatants by ELISA according to the
manufacturer’s instructions; Bovine IL-6 Screening Set (ESS0029;
Thermo fisher scientific, Cramlington, UK). Bovine IL-8 was
measured by ELISA as described previously.47
Immunoblotting. Cell lysate proteins were normalized to 1 mg ml 1
using the DC Assay (Bio-Rad, Hemel Hempstead, UK) and separated
(10 mg per lane) using 10% (vol/vol) SDS-polyacrylamide gel elec-
trophoresis, withmolecularweightmarkers in parallel lanes (Bio-Rad).
After electrophoresis, proteins were transferred to a polyvinylidene
difloride membrane (Bio-Rad); nonspecific binding was blocked using
5% (wt/vol) bovine serum albumin (Sigma) in Tris-buffered saline
(Sigma) for 1 h at 37 1C. Membranes were probed with antibodies
targeting phosphorylated STAT3 (Y705) (#9145, Cell Signaling,
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Danvers, MA), STAT3 (#9139, Cell Signaling), or SOCS3 (#2932,
Cell Signaling). Protein loading was evaluated and normalized
by examining a-tubulin levels using a-tubulin antibody (#2144;
Cell Signaling). Primary antibodies were used at 1:1,000 dilutions
in Tris-buffered saline, 0.1% Tween 20 (pH 7.6; Sigma) overnight
at 41C. Membranes were washed and incubated in secondary
horseradish peroxidase-conjugated antibody (Cell Signaling)
in 5% (wt/vol) bovine serum albumin in Tris-buffered saline
for 1.5 h, and then washed. Steady-state levels of immunoreactive
proteinswere visualized using enhanced chemiluminescence (Western
C, Bio-Rad), and densitometry on nonsaturated immunoblots was
measured using the ChemiDoc System and Quantity-one software
(Bio-Rad).
Nuclear and cytoplasmic protein extraction. Nuclear and
cytoplasmic proteins were extracted according to the manufacturer’s
instructions (Active Motif Europe, Rixensart, Belgium). Briefly, cells
were grown to B70% confluency, treated, and collected in ice-cold
PBS containing phosphatase inhibitors, and hypotonic buffer used to
make the cell membrane fragile. A detergent allowed leakage of
cytoplasmic proteins and their collection in supernatant. Nuclei were
lysed and nuclear proteins solubilized in lysis buffer containing
protease inhibitors. Nuclear and cytoplasmic proteins were separated
(5mg per lane) using 10% (vol/vol) SDS-polyacrylamide gel
electrophoresis, and immunoblotted as before, using a-tubulin andH3
(ab1791, Abcam) to assess cytoplasmic and nuclear fraction purity,
respectively.
Short interfering RNA. Endometrial epithelial and stromal cells were
transfected with Lipofectamine RNAiMAX Reagent (Invitrogen,
Waltham, MA) and siRNA (designed using Dharmacon’s siDESIGN
Center, gelifesciences.com) targeting IL6R, STAT3, or SOCS3 (duplex
sequences in Supplementary Table 1 online). Briefly, RNAiMAX–
RNAi duplex complexes were formed by adding 50 pmol of siRNA to
500 ml of Opti-MEM Imedium (11058-021, Invitrogen) in each well of
a six-well plate, with 50 pmol of ON-TARGETplus Non-targeting
siRNA #1 (Dharmacon; gelifesciences.com) as a control. Then, 7.5 ml
RNAiMAX was added to each well containing the diluted RNAi
molecules and incubated for 20min at room temperature. Expo-
nentially growing cells (7 105 epithelial cells, 5 105 stromal cells)
were then seeded in 2.5ml per well of RPMI 1640 growth media,
supplemented with 10% fetal bovine serum. All transfections were
replicated in triplicate, and LPS (1 mgml 1) treatments were carried
out in OPTI-MEM medium within 48 h for RNA studies, or 72 h for
protein studies.
Quantitative PCR (qPCR). Cells were washed with PBS, and RNA
extracted using the RNeasy Mini Kit and automated Qiacube system,
according to the manufacturer’s instructions (Qiagen, Crawley, UK).
Extracted RNA was quantified (Nanodrop ND1000 spectro-
photometer, Labtech, Ringmer, UK), and 1 mg of total RNA added to a
genomic DNA elimination reaction, followed by conversion to cDNA
(Quantitect Reverse Transcription Kit, Qiagen), according to the
manufacturer’s instructions. Quantitative PCR was performed using
intron-spanning primers (Supplementary Table S2) and the IQ5
system (Bio-Rad, Hemel Hempstead, UK). The starting quantity
of mRNA from experimental samples were determined using
standard curves generated from serial dilutions of pooled reference
RNA with Quantifast SYBR green (Qiagen). Sample and reference
genes were analyzed in triplicate, andmRNAexpression normalized to
ACTB and RPL19 (Supplementary Table S2) using the IQ5 system
(Bio-Rad), with inter-run correlation and run-dependent differences
corrected using qBase software on the IQ5 system (Bio-Rad).48 The
ACTB and RPL19 reference genes did not differ in expression with
treatment, were amplified at the same efficiency as the target gene, and
had target stability meanM values below recommended thresholds of
o0.3 and o0.6 for epithelial (homogenous) and stromal cells
(heterogeneous), respectively.48
Co-immunoprecipitation. Stromal cells grown to 90% confluence in
150 cm2 flasks were exposed to 1 mgml 1 ultrapure LPS (InvivoGen)
for 0, 30, or 60min. Immunoprecipitations were carried out with
25mgml 1 total protein and 50 mg monoclonal antibody RAS P21
Protein Activator 2 (RasGAP; Abcam, ab13057) linked to 10 ng of
Dynabeads (Life Technologies, Paisley, UK) and incubated for 2 h at
room temperature. For immunoblot analysis, immunoprecipitated
protein was detected using RasGAP antibody (Abcam, ab13057) or
SOCS3 (#2932, Cell Signaling).
Inhibitors. Endometrial cells were incubated for 30min before and
during exposure to 1 mgml 1 LPS with the following inhibitors:
Stattic (6-nitrobenzo[b]thiophene-1,1-dioxide; Millipore, UK);
ERK1/2 activation inhibitor peptide I (Merck, Nottingham, UK);
farnesyl thiosalicylic acid (Santa Cruz Biotechnology, Inc.,
Heidelberg, Germany); Ruxolitinib (RUX; InvivoGen); PP1 (1-(1,1-
dimethylethyl)-3-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-
amine; Cayman Chemical, Cambridge, UK); using dimethyl sulfoxide
as vehicle control. Cell viability was evaluated at 6 or 24 h by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.
Co-culture. Polarized epithelial cells were prepared by seeding 3 105
cells on each Millicell hanging cell culture insert (Millipore, Watford,
UK), pre-coated with Matrigel (BD Biosciences, Heidelberg,
Germany), and placed in 24-well plates (TPP, Helena Biosciences,
Gateshead, UK), with 300 and 800 ml RPMI culture medium
(supplemented with 10% fetal bovine serum, 50 IUml 1 of penicillin,
50 mgml 1 of streptomycin and 2.5mgml 1 of amphotericin B) in the
apical and basolateral compartment, respectively, as described.49
Epithelial layer confluence was determined by trans-epithelial
resistance41,000Ocm.49 Stromal cells were seeded (1 104) into the
basolateral compartment of the culture plates below the polarized
epithelial cells or cell-free inserts 24 h before treatment. Cells were then
co-cultured and treated for a further 24 h with OPTI-MEM media
alone or containing LPS, with or without Stattic (2mM) in the
basolateral compartment. Experiments were repeated using three
animals, and basolateral supernatants collected for ELISA.
Statistics. The animal was designated as the statistical unit, and data
presented as mean (s.e.m.). Treatments were compared by analysis of
variance (ANOVA) with Bonferroni’s or Dunnett’s post-comparison
test, using SPSS 16.0 (SPSS, IBM Corp., Armonk, NY), with Po0.05
regarded as significant.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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